VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
* Login to view program details and full enterprise executive list.
DATE
JUL 2020
TABLES
54
PAGES
171
EDITION
20
PRICE
USD $5450
Easy Growth Opportunities Often Go Unnoticed. Find Your "Low Hanging Fruit".
Top Markets for Personalized Medicines.
INSIDER ACCESS PRIVILEGES
KEY DIFFERENTIATORS
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlassâ„¢ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Access to Valuable Genetic Information Ushers Transformation in Medicine |
| Recent Market Activity |
| Market Outlook |
| Adoption of Personalized Medicines - A Peek into Developed and Developing Economies |
| Increasing Market Availability of Personalized Medicines |
| Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area |
| Constraints in Traditional Approach to Treatment Creates Need and Demand for Personalized Medicine |
| Economics of Personalized Medicine |
| Is Emergence of Personalized Medicine Signaling the End of Blockbusters? |
| Global Competitor Market Shares |
| Personalized Medicines Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Abbott Molecular, Inc. (USA) |
| Beckman Coulter Genomics (USA) |
| bioMérieux SA (France) |
| Bristol-Myers Squibb Company (USA) |
| Dako Denmark A/S (Denmark) |
| F. Hoffmann-La Roche Ltd. (Switzerland) |
| GlaxoSmithKline plc. (UK) |
| Hologic, Inc. (USA) |
| Lab 21 Limited (UK) |
| Macrogen, Inc. (Korea) |
| NeoGenomics Laboratories, Inc. (USA) |
| Novartis AG (Switzerland) |
| QIAGEN NV (The Netherlands) |
| Rosetta Genomics Ltd (Israel) |
| Thermo Fisher Scientific Inc. (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Growth Drivers in a Gist |
| Key Market Restraints |
| Increasing Incidence and Prevalence of CDDs: A Major Growth Driver |
| Oncology - A Major Application Market |
| Diagnosed Cases of Cancer on the Rise |
| World Cancer Statistics: Incidence and Mortality Data |
| Growing Cancer Cases in Developing Countries Bodes Well for the Personalized Medicine Market |
| Growing Importance of Personalized Drugs for Cancer Treatment |
| Ballooning Global Population Offers Significant Growth Opportunities |
| Aging Global Population Drives Personalized Medicines |
| Increasing Healthcare Spending in Emerging Markets |
| Changing Patients' Trends Drive Personalized Medicine |
| Technological Advancements and Consumer Push to Drive Personalized Medicine |
| Minimizing Adverse Events - A Major Benefit of Personalized Medicines |
| Personalized Medicines Brings Disease Prevention Closer to Reality |
| Ability to Manage Healthcare Costs Piques Industry and Government Alike |
| Potential to Uncover Additional Prospective Targets - A Major Benefit in Pursuit |
| Elimination of Invasive Tests Attracts Patients and Doctors towards Molecular Test-based Personalized Medicines |
| Genomics to Dictate Advancement of Personalized Medicines |
| Companion Diagnostics Drive Personalized Medicine |
| Biomarkers as Companion Diagnostics |
| Personalized Medicines Help Reducing R&D Costs |
| Personalized Medicine - A Corporate Growth Strategy |
| Development Pipeline Reveals Promising Picture for Personalized Medicine |
| Advancements in Biomedical Imaging to Enhance Personalized Medicines |
| Increasing Use of Personalized Medicines Drives Genetic Testing |
| Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market |
| Next-Generation Sequencing - A Giant Leap in Genome Sequencing |
| Single Nucleotide Polymorphism (SNP) - Making Advancements in Personalized Medicine |
| Personalized Medicine Goes Beyond DNA Analysis |
| Combination Approaches May Mark Future Endeavors |
| Need for New Designs in Clinical Trials Emerges in Therapies for Rare Cancers |
| Immunotherapy for Cancers - A Potential Breakthrough in the Sector |
| Personalized Medicine Industry - Inundated with Data |
| Advanced Computing Technologies - The Need of The Hour to Analyze Large Data |
| Artificial Intelligence Revolutionizing Personalized Medicine |
| Challenges Aplenty for Precision Medicine |
| Lack of Clinically Useful Diagnostic Tests - Growth Dampener |
| Pricing and Value Dilemma Haunts Personalized Medicines |
| Bedside Biopharmaceutical Production to Dramatically Reduce Cost of Personalized Medicine |
| 4. GLOBAL MARKET PERSPECTIVE |
| Personalized Medicines Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Personalized Medicines Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Personalized Medicines Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Tests & Lab Services (Type) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Tests & Lab Services (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Tests & Lab Services (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Targeted Therapeutics (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Targeted Therapeutics (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Targeted Therapeutics (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Personalized Medicines Market Share (in %) by Company: 2018 & 2025 |
| United States Personalized Medicines Market Estimates and Projections in US$ Million by Type: 2018 to 2025 |
| Personalized Medicines Market in the United States by Type: A Historic Review in US$ Million for 2009-2017 |
| United States Personalized Medicines Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Canada |
| Canadian Personalized Medicines Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 |
| Canadian Personalized Medicines Historic Market Review by Type in US$ Million: 2009-2017 |
| Personalized Medicines Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 |
| Japan |
| Japanese Market for Personalized Medicines: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025 |
| Personalized Medicines Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 |
| Japanese Personalized Medicines Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| China |
| Chinese Personalized Medicines Market Growth Prospects in US$ Million by Type for the Period 2018-2025 |
| Personalized Medicines Historic Market Analysis in China in US$ Million by Type: 2009-2017 |
| Chinese Personalized Medicines Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Europe |
| Market Facts & Figures |
| European Personalized Medicines Market: Competitor Market Share Scenario (in %) for 2018 & 2025 |
| European Personalized Medicines Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Personalized Medicines Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Personalized Medicines Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Personalized Medicines Market Estimates and Forecasts in US$ Million by Type: 2018-2025 |
| Personalized Medicines Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017 |
| European Personalized Medicines Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| France |
| Personalized Medicines Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Personalized Medicines Historic Market Scenario in US$ Million by Type: 2009-2017 |
| French Personalized Medicines Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Germany |
| Personalized Medicines Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 |
| German Personalized Medicines Historic Market Analysis in US$ Million by Type: 2009-2017 |
| German Personalized Medicines Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Italy |
| Italian Personalized Medicines Market Growth Prospects in US$ Million by Type for the Period 2018-2025 |
| Personalized Medicines Historic Market Analysis in Italy in US$ Million by Type: 2009-2017 |
| Italian Personalized Medicines Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| United Kingdom |
| United Kingdom Market for Personalized Medicines: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025 |
| Personalized Medicines Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 |
| United Kingdom Personalized Medicines Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Personalized Medicines Market Estimates and Forecasts in US$ Million by Type: 2018-2025 |
| Personalized Medicines Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017 |
| Rest of Europe Personalized Medicines Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Asia-Pacific |
| Personalized Medicines Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Personalized Medicines Historic Market Scenario in US$ Million by Type: 2009-2017 |
| Asia-Pacific Personalized Medicines Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Rest of World |
| Rest of World Personalized Medicines Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 |
| Rest of World Personalized Medicines Historic Market Review by Type in US$ Million: 2009-2017 |
| Personalized Medicines Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 87 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com